Prestige Consumer Healthcare (PBH) Competitors

$46.69 +0.76 (+1.65%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$46.71 +0.02 (+0.04%)

As of 05/15/2026 06:54 PM Eastern

PBH vs. IPAR, HLF, NATR, USNA, and NUS

Should you buy Prestige Consumer Healthcare stock or one of its competitors? MarketBeat compares Prestige Consumer Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Prestige Consumer Healthcare include Interparfums (IPAR), Herbalife (HLF), Nature's Sunshine Products (NATR), USANA Health Sciences (USNA), and Nu Skin Enterprises (NUS). These companies are all part of the "personal products" industry.

How does Prestige Consumer Healthcare compare to Interparfums?

Prestige Consumer Healthcare (NYSE:PBH) and Interparfums (NASDAQ:IPAR) are both mid-cap personal products companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

Prestige Consumer Healthcare has a net margin of 17.48% compared to Interparfums' net margin of 11.32%. Interparfums' return on equity of 15.47% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	17.48%	11.54%	6.16%
Interparfums	11.32%	15.47%	10.82%

Prestige Consumer Healthcare has higher earnings, but lower revenue than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.09B	2.03	$214.60M	$3.91	11.94
Interparfums	$1.49B	1.85	$168.39M	$5.27	16.35

In the previous week, Prestige Consumer Healthcare had 15 more articles in the media than Interparfums. MarketBeat recorded 20 mentions for Prestige Consumer Healthcare and 5 mentions for Interparfums. Interparfums' average media sentiment score of 1.47 beat Prestige Consumer Healthcare's score of 0.11 indicating that Interparfums is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	4 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Interparfums	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Prestige Consumer Healthcare has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.16, meaning that its share price is 16% more volatile than the broader market.

Prestige Consumer Healthcare currently has a consensus price target of $70.75, indicating a potential upside of 51.53%. Interparfums has a consensus price target of $105.20, indicating a potential upside of 22.10%. Given Prestige Consumer Healthcare's higher probable upside, research analysts clearly believe Prestige Consumer Healthcare is more favorable than Interparfums.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Interparfums	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.6% of Interparfums shares are owned by institutional investors. 1.4% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 43.7% of Interparfums shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Interparfums beats Prestige Consumer Healthcare on 11 of the 17 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to Herbalife?

Prestige Consumer Healthcare (NYSE:PBH) and Herbalife (NYSE:HLF) are both personal products companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Prestige Consumer Healthcare has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, Herbalife has a beta of 0.98, meaning that its share price is 2% less volatile than the broader market.

Herbalife has higher revenue and earnings than Prestige Consumer Healthcare. Herbalife is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.09B	2.03	$214.60M	$3.91	11.94
Herbalife	$5.04B	0.26	$228.30M	$2.28	5.62

100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 1.4% of Prestige Consumer Healthcare shares are held by insiders. Comparatively, 5.1% of Herbalife shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Prestige Consumer Healthcare had 9 more articles in the media than Herbalife. MarketBeat recorded 20 mentions for Prestige Consumer Healthcare and 11 mentions for Herbalife. Herbalife's average media sentiment score of 0.48 beat Prestige Consumer Healthcare's score of 0.11 indicating that Herbalife is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	4 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Herbalife	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Prestige Consumer Healthcare has a net margin of 17.48% compared to Herbalife's net margin of 4.67%. Prestige Consumer Healthcare's return on equity of 11.54% beat Herbalife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	17.48%	11.54%	6.16%
Herbalife	4.67%	-41.47%	8.24%

Prestige Consumer Healthcare currently has a consensus target price of $70.75, suggesting a potential upside of 51.53%. Herbalife has a consensus target price of $17.80, suggesting a potential upside of 38.92%. Given Prestige Consumer Healthcare's higher probable upside, equities research analysts plainly believe Prestige Consumer Healthcare is more favorable than Herbalife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Herbalife	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Prestige Consumer Healthcare and Herbalife tied by winning 8 of the 16 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to Nature's Sunshine Products?

Nature's Sunshine Products (NASDAQ:NATR) and Prestige Consumer Healthcare (NYSE:PBH) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

Nature's Sunshine Products has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market. Comparatively, Prestige Consumer Healthcare has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

Prestige Consumer Healthcare has higher revenue and earnings than Nature's Sunshine Products. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nature's Sunshine Products	$489.79M	0.80	$19.52M	$1.10	20.20
Prestige Consumer Healthcare	$1.09B	2.03	$214.60M	$3.91	11.94

79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. 3.1% of Nature's Sunshine Products shares are owned by company insiders. Comparatively, 1.4% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Prestige Consumer Healthcare has a net margin of 17.48% compared to Nature's Sunshine Products' net margin of 4.06%. Nature's Sunshine Products' return on equity of 14.67% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nature's Sunshine Products	4.06%	14.67%	9.27%
Prestige Consumer Healthcare	17.48%	11.54%	6.16%

Nature's Sunshine Products presently has a consensus target price of $35.00, indicating a potential upside of 57.52%. Prestige Consumer Healthcare has a consensus target price of $70.75, indicating a potential upside of 51.53%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, analysts plainly believe Nature's Sunshine Products is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Prestige Consumer Healthcare	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Prestige Consumer Healthcare had 13 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 20 mentions for Prestige Consumer Healthcare and 7 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.19 beat Prestige Consumer Healthcare's score of 0.11 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nature's Sunshine Products	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	4 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Nature's Sunshine Products beats Prestige Consumer Healthcare on 9 of the 16 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Prestige Consumer Healthcare (NYSE:PBH) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Prestige Consumer Healthcare had 19 more articles in the media than USANA Health Sciences. MarketBeat recorded 20 mentions for Prestige Consumer Healthcare and 1 mentions for USANA Health Sciences. USANA Health Sciences' average media sentiment score of 0.50 beat Prestige Consumer Healthcare's score of 0.11 indicating that USANA Health Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	4 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Prestige Consumer Healthcare has higher revenue and earnings than USANA Health Sciences. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.36	$10.76M	$0.47	38.30
Prestige Consumer Healthcare	$1.09B	2.03	$214.60M	$3.91	11.94

Prestige Consumer Healthcare has a net margin of 17.48% compared to USANA Health Sciences' net margin of 0.96%. Prestige Consumer Healthcare's return on equity of 11.54% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Prestige Consumer Healthcare	17.48%	11.54%	6.16%

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 1.4% of Prestige Consumer Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

USANA Health Sciences has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Prestige Consumer Healthcare has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market.

Prestige Consumer Healthcare has a consensus price target of $70.75, indicating a potential upside of 51.53%. Given Prestige Consumer Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Prestige Consumer Healthcare is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Prestige Consumer Healthcare	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Prestige Consumer Healthcare beats USANA Health Sciences on 13 of the 16 factors compared between the two stocks.

How does Prestige Consumer Healthcare compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and Prestige Consumer Healthcare (NYSE:PBH) are both personal products companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Prestige Consumer Healthcare has lower revenue, but higher earnings than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.20	$160.20M	$1.10	5.58
Prestige Consumer Healthcare	$1.09B	2.03	$214.60M	$3.91	11.94

Nu Skin Enterprises has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market. Comparatively, Prestige Consumer Healthcare has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by insiders. Comparatively, 1.4% of Prestige Consumer Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Prestige Consumer Healthcare has a consensus target price of $70.75, suggesting a potential upside of 51.53%. Given Prestige Consumer Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Prestige Consumer Healthcare is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Prestige Consumer Healthcare	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Prestige Consumer Healthcare had 16 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 20 mentions for Prestige Consumer Healthcare and 4 mentions for Nu Skin Enterprises. Nu Skin Enterprises' average media sentiment score of 0.29 beat Prestige Consumer Healthcare's score of 0.11 indicating that Nu Skin Enterprises is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nu Skin Enterprises	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Prestige Consumer Healthcare	4 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Prestige Consumer Healthcare has a net margin of 17.48% compared to Nu Skin Enterprises' net margin of 3.78%. Prestige Consumer Healthcare's return on equity of 11.54% beat Nu Skin Enterprises' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Prestige Consumer Healthcare	17.48%	11.54%	6.16%

Summary

Prestige Consumer Healthcare beats Nu Skin Enterprises on 12 of the 16 factors compared between the two stocks.

Get Prestige Consumer Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PBH vs. The Competition

Export

Metric	Prestige Consumer Healthcare	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$2.21B	$8.17B	$6.38B	$22.77B
Dividend Yield	N/A	2.54%	2.81%	4.12%
P/E Ratio	11.94	15.79	20.66	29.73
Price / Sales	2.03	7.37	555.40	23.46
Price / Cash	8.98	16.48	42.43	24.78
Price / Book	1.17	3.78	9.87	4.60
Net Income	$214.60M	$223.05M	$3.57B	$1.07B
7 Day Performance	-11.11%	-3.49%	0.23%	-2.27%
1 Month Performance	-19.50%	-2.59%	-2.54%	-1.66%
1 Year Performance	-47.68%	-0.20%	33.54%	21.95%

Prestige Consumer Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PBH Prestige Consumer Healthcare	3.7469 of 5 stars	$46.69 +1.7%	$70.75 +51.5%	-47.7%	$2.21B	$1.09B	11.94	540	Trending News Earnings Report Analyst Downgrade High Trading Volume
IPAR Interparfums	4.6313 of 5 stars	$92.28 +2.2%	$105.20 +14.0%	-32.0%	$2.90B	$1.49B	17.18	530
HLF Herbalife	4.5783 of 5 stars	$13.59 -5.0%	$17.80 +31.0%	+81.9%	$1.48B	$5.04B	5.92	8,500	Insider Trade
NATR Nature's Sunshine Products	4.175 of 5 stars	$22.23 +0.2%	$35.00 +57.5%	+49.4%	$389.84M	$480.14M	20.16	850	Positive News High Trading Volume
USNA USANA Health Sciences	2.5095 of 5 stars	$17.55 -7.4%	N/A	-40.5%	$349.94M	$925.26M	37.13	1,570

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PBH) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Prestige Consumer Healthcare (PBH) Competitors

PBH vs. IPAR, HLF, NATR, USNA, and NUS

How does Prestige Consumer Healthcare compare to Interparfums?

Summary

How does Prestige Consumer Healthcare compare to Herbalife?

Summary

How does Prestige Consumer Healthcare compare to Nature's Sunshine Products?

Summary

How does Prestige Consumer Healthcare compare to USANA Health Sciences?

Summary

How does Prestige Consumer Healthcare compare to Nu Skin Enterprises?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBH vs. The Competition

Prestige Consumer Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Prestige Consumer Healthcare (PBH) Competitors

PBH vs. IPAR, HLF, NATR, USNA, and NUS

How does Prestige Consumer Healthcare compare to Interparfums?

Is PBH or IPAR more profitable?

Which has preferable earnings and valuation, PBH or IPAR?

Does the media refer more to PBH or IPAR?

Which has more risk and volatility, PBH or IPAR?

Do analysts recommend PBH or IPAR?

Do insiders & institutionals have more ownership in PBH or IPAR?

Summary

How does Prestige Consumer Healthcare compare to Herbalife?

Which has more risk and volatility, PBH or HLF?

Which has higher earnings and valuation, PBH or HLF?

Do institutionals and insiders believe in PBH or HLF?

Does the media favor PBH or HLF?

Is PBH or HLF more profitable?

Do analysts prefer PBH or HLF?

Summary

How does Prestige Consumer Healthcare compare to Nature's Sunshine Products?

Which has more volatility & risk, NATR or PBH?

Which has higher earnings and valuation, NATR or PBH?

Do insiders & institutionals have more ownership in NATR or PBH?

Is NATR or PBH more profitable?

Do analysts rate NATR or PBH?

Does the media favor NATR or PBH?

Summary

How does Prestige Consumer Healthcare compare to USANA Health Sciences?

Does the media favor USNA or PBH?

Which has better earnings & valuation, USNA or PBH?

Is USNA or PBH more profitable?

Do institutionals and insiders hold more shares of USNA or PBH?

Which has more volatility and risk, USNA or PBH?

Do analysts prefer USNA or PBH?

Summary

How does Prestige Consumer Healthcare compare to Nu Skin Enterprises?

Which has better earnings and valuation, NUS or PBH?

Which has more volatility and risk, NUS or PBH?

Do insiders & institutionals have more ownership in NUS or PBH?

Do analysts recommend NUS or PBH?

Does the media refer more to NUS or PBH?

Is NUS or PBH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBH vs. The Competition

Prestige Consumer Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools